ABVC BioPharma Inc (NASDAQ:ABVC) price on Friday, April 11, fall -12.95% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.91.
A look at the stock’s price movement, the close in the last trading session was $1.05, moving within a range at $0.901 and $1.085. The beta value (5-Year monthly) was 0.326. Turning to its 52-week performance, $1.73 and $0.40 were the 52-week high and 52-week low respectively. Overall, ABVC moved 32.85% over the past month.
ABVC BioPharma Inc’s market cap currently stands at around $11.86 million, with investors looking forward to this quarter’s earnings report slated for on 2023-May-14.
Turning to the stock’s technical picture we see that short term indicators suggest on average that ABVC is a 100% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 50% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 0 recommend ABVC as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Hold which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ABVC’s current price about 8.19% and 32.03% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 53.81, while 7-day volatility ratio is 33.68% and 18.28% in the 30-day chart. Further, ABVC BioPharma Inc (ABVC) has a beta value of 0.05, and an average true range (ATR) of 0.16.
If we refocus on ABVC BioPharma Inc (NASDAQ:ABVC), historical trading data shows that trading volumes averaged 1.12 over the past 10 days and 654.05K over the past 3 months. The company’s latest data on shares outstanding shows there are 12.71 million shares.
The 13.39% of ABVC BioPharma Inc’s shares are in the hands of company insiders while institutional holders own 3.15% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.32 million on 2025-03-14, giving us a short ratio of 0.24. The data shows that as of 2025-03-14 short interest in ABVC BioPharma Inc (ABVC) stood at 154.0 of shares outstanding, with shares short rising to 0.26 million registered in 2025-02-14. Current price change has pushed the stock 54.92% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ABVC stock continues to rise going into the next quarter.
